Found: 19
Select item for more details and to access through your institution.
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for gastric and biliary tract cancer and encorafenib and binimetinib for thyroid cancer in Japan.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1053, doi. 10.1007/s10147-024-02562-8
- By:
- Publication type:
- Article
The efficacy and safety of anamorelin among patients with diabetes.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1115, doi. 10.1007/s10147-024-02546-8
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis with G-CSF for patients with Ewing sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1081, doi. 10.1007/s10147-024-02572-6
- By:
- Publication type:
- Article
Pancreatic cancer and sarcopenia: a narrative review of the current status.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1055, doi. 10.1007/s10147-024-02576-2
- By:
- Publication type:
- Article
Urological cancer statistics on incidence from 1975 to 2019 and mortality from 1958 to 2022 in Japan.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1088, doi. 10.1007/s10147-024-02575-3
- By:
- Publication type:
- Article
Zinc supplementation for dysgeusia in patients with unresectable pancreatic cancer.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1173, doi. 10.1007/s10147-024-02544-w
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis with G-CSF during chemotherapy for invasive breast cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the Use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1074, doi. 10.1007/s10147-024-02570-8
- By:
- Publication type:
- Article
Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1067, doi. 10.1007/s10147-024-02569-1
- By:
- Publication type:
- Article
Impact of cancer cachexia on survival in patients with pancreatic cancer and the efficacy of first-line chemotherapy.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1204, doi. 10.1007/s10147-024-02564-6
- By:
- Publication type:
- Article
New predictors of microvascular invasion for small hepatocellular carcinoma ≤ 3 cm.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1182, doi. 10.1007/s10147-024-02553-9
- By:
- Publication type:
- Article
Appropriate definition of non-metastatic castration-resistant prostate cancer (nmCRPC) and optimal timing of androgen receptor signaling inhibitor (ARSI).
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1198, doi. 10.1007/s10147-024-02549-5
- By:
- Publication type:
- Article
Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1191, doi. 10.1007/s10147-024-02548-6
- By:
- Publication type:
- Article
Safety and efficacy of neoadjuvant chemotherapy with paclitaxel, carboplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1133, doi. 10.1007/s10147-024-02545-9
- By:
- Publication type:
- Article
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1142, doi. 10.1007/s10147-024-02543-x
- By:
- Publication type:
- Article
Prognostic value of a mandibular canal staging system for primary lesions in patients with lower gingival squamous cell carcinoma: a multicenter, retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1122, doi. 10.1007/s10147-024-02542-y
- By:
- Publication type:
- Article
Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1161, doi. 10.1007/s10147-024-02540-0
- By:
- Publication type:
- Article
Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1096, doi. 10.1007/s10147-024-02526-y
- By:
- Publication type:
- Article
Prognostic impact of the combination of p16<sup>INK4a</sup>, p21 and Immunoscore in rectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1152, doi. 10.1007/s10147-024-02519-x
- By:
- Publication type:
- Article
Current status and future perspective of immunotherapy for renal cell carcinoma.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1105, doi. 10.1007/s10147-023-02446-3
- By:
- Publication type:
- Article